Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Kiora Pharmaceuticals, Inc. (KPRX) had Weighted-Average Shares Outstanding (Diluted) of 3.99M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.15M |
|
-- |
|
-- |
|
$2.40M |
|
$-2.40M |
|
$0.13M |
|
$-2.26M |
|
$-2.26M |
|
$-2.15M |
|
$-2.15M |
|
$-2.15M |
|
$-2.15M |
|
$-2.40M |
|
$-2.39M |
|
3.99M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
3.99M |
$-0.54 |
|
$-0.54 |
|
| Balance Sheet Financials | |
$24.74M |
|
$0.11M |
|
$7.21M |
|
$31.95M |
|
$3.19M |
|
-- |
|
$6.63M |
|
$9.82M |
|
$22.13M |
|
$15.44M |
|
$22.13M |
|
3.43M |
|
| Cash Flow Statement Financials | |
$-6.51M |
|
$3.34M |
|
$0.27M |
|
$3.80M |
|
$1.03M |
|
$-2.76M |
|
$0.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.73% |
|
-13.94% |
|
-6.74% |
|
-9.73% |
|
$6.45 |
|
$-1.64 |
|
$-1.63 |
|